Stoke Therapeutics Ownership | Who Owns Stoke Therapeutics?
Stoke Therapeutics Ownership Summary
Stoke Therapeutics is owned by 103.33% institutional investors, 4.67% insiders. Skorpios trust is the largest institutional shareholder, holding 23.45% of STOK shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.97% of its assets in Stoke Therapeutics shares.
STOK Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Stoke Therapeutics | 103.33% | 4.67% | -8.00% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Skorpios trust | 10.84M | 23.45% | $146.50M |
Blackrock | 5.41M | 11.70% | $73.08M |
Lynx1 capital management lp | 5.19M | 11.21% | $70.05M |
Redmile group | 4.72M | 10.21% | $63.78M |
Baker bros. advisors lp | 4.37M | 9.45% | $59.02M |
Rtw investments, lp | 4.22M | 9.14% | $57.08M |
Morgan stanley | 3.48M | 7.52% | $47.00M |
Cowen and company | 3.37M | 7.28% | $45.47M |
Vanguard group | 2.69M | 5.81% | $36.31M |
State street | 1.59M | 3.44% | $21.50M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Skorpios trust | 10.84M | 99.89% | $146.50M |
Lynx1 capital management lp | 5.19M | 4.54% | $70.05M |
Redmile group | 4.72M | 3.86% | $63.78M |
Birchview capital, lp | 210.00K | 2.63% | $2.84M |
Cowen and company | 3.37M | 1.25% | $45.47M |
Rtw investments, lp | 4.22M | 0.88% | $57.08M |
Baker bros. advisors lp | 4.37M | 0.75% | $59.02M |
Dafna capital management | 207.43K | 0.67% | $2.80M |
Cormorant asset management, lp | 427.16K | 0.33% | $5.77M |
Granahan investment management | 598.40K | 0.32% | $8.08M |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Blackrock | 5.41M | 0.00% | 1.55M |
Lynx1 capital management lp | 5.19M | 4.54% | 1.49M |
State street | 1.59M | 0.00% | 1.01M |
Baker bros. advisors lp | 4.37M | 0.75% | 1.00M |
Marshall wace, llp | 1.16M | 0.02% | 982.45K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Skorpios trust | 10.84M | 99.89% | -3.60M |
Healthcare of ontario pension plan trust fund | - | - | -1.39M |
Logos global management lp | - | - | -1.05M |
Morgan stanley | 3.48M | 0.00% | -546.21K |
Deutsche bank ag\ | 16.03K | 0.00% | -396.21K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Invesco | 437.14K | 0.00% | 437.14K | $5.91M |
Voloridge investment management | 198.28K | 0.01% | 198.28K | $2.68M |
Rafferty asset management | 79.89K | 0.00% | 79.89K | $1.08M |
Swiss national bank | 66.40K | 0.00% | 66.40K | $897.06K |
Ubs asset management americas | 57.40K | 0.00% | 57.40K | $775.46K |
Sold Out
Holder | Change |
---|---|
Nelson, van denburg & campbell wealth management group | -5.00 |
Quarry lp | -118.00 |
Srs capital advisors | -173.00 |
Lazard asset management | -213.00 |
Pacer advisors | -454.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 120 | 3.45% | 58,218,197 | -5.03% | 103 | 0.59% | 61 | -25.61% | 36 | 63.64% |
Jun 30, 2024 | 116 | 5.45% | 61,304,739 | 13.13% | 132 | 0.97% | 82 | 17.14% | 22 | -15.38% |
Mar 31, 2024 | 110 | 32.53% | 54,189,692 | 20.45% | 117 | 1.17% | 70 | 112.12% | 26 | -18.75% |
Dec 31, 2023 | 83 | -17.00% | 44,987,632 | 2.40% | 100 | 1.02% | 33 | -23.26% | 32 | -11.11% |
Sep 30, 2023 | 100 | -5.66% | 43,931,099 | -5.62% | 99 | 0.89% | 43 | -20.37% | 36 | 28.57% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
Vanguard Total Stock Mkt Idx Inv | 1.57M | 2.97% | - |
BlackRock Health Sciences Opps Inv A | 969.34K | 1.83% | - |
iShares Russell 2000 ETF | 953.19K | 1.80% | -3.65K |
BGF World Healthscience A2 | 851.11K | 1.61% | - |
SPDR® S&P Biotech ETF | 765.79K | 1.45% | -8.94K |
Vanguard Institutional Extnd Mkt Idx Tr | 592.24K | 1.12% | 15.26K |
BlackRock Health Sciences Term Trust | 530.09K | 1.00% | - |
M&G (ACS) Granahan US Sm Cp Gr GBPZ1AAcc | 414.93K | 0.79% | 14.31K |
Fidelity Small Cap Index | 365.16K | 0.69% | 2.11K |
iShares Russell 2000 Growth ETF | 328.21K | 0.62% | - |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 23, 2024 | Skorpios Trust | - | Sell | $23.00M |
Dec 09, 2024 | Ticho Barry | CHIEF MEDICAL OFFICER | Sell | $33.60K |
Dec 09, 2024 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | $20.16K |
Dec 09, 2024 | Allan Jonathan | GENERAL COUNSEL & CORP SEC | Sell | $165.81K |
Dec 09, 2024 | Kaye Edward M. MD | CEO | Sell | $88.16K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | - | 10 |
2024 Q3 | - | 7 |
2024 Q2 | - | 11 |
2024 Q1 | - | 10 |
2023 Q4 | - | - |
STOK Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools